Research Article

Network Pharmacology and Rat Caudal-disc Puncture Validation of Yi Qi Huo Xue Decoction For Lumbar Disc Degeneration

DOI:

10.3791/71410

⸱

May 26th, 2026

In This Article

Summary

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

This study used network pharmacology, molecular docking, and a rat caudal-disc puncture model to investigate the potential preclinical effects of Yi Qi Huo Xue Decoction on lumbar disc degeneration, with a focus on candidate targets, including AKT1, BCL2, and STAT3, and pathways such as PI3K-AKT signaling.

Abstract

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

In this study, network pharmacology, molecular docking, molecular dynamics simulation, and experimental validation were used to investigate the pharmacological basis and potential molecular mechanisms of Yi Qi Huo Xue Decoction (YQHXD) in lumbar disc degeneration (LDD). A total of 678 active compound-related targets of YQHXD and 296 potential LDD-associated therapeutic targets were identified. Protein-protein interaction network analysis and topological analysis identified several candidate targets, including AKT1, IL6, TNF, BCL2, and STAT3. Enrichment analyses using Gene Ontology and Kyoto Encyclopedia of Genes and Genomes indicated that the candidate targets were linked to functions including protein binding and ATP binding, with pathway enrichment that included PI3K-AKT signaling. Molecular docking predicted interactions between selected active compounds, such as quercetin, Tetraneurin A, and isorhamnetin, and the core targets. Molecular dynamics simulations further suggested that the lowest-energy complexes remained stable. Seventy male Sprague-Dawley rats were randomly assigned to the control, sham-operated, model, positive control, and low-, medium-, and high-dose YQHXD groups. After the establishment of a coccygeal intervertebral disc puncture model in the model, positive control, and YQHXD groups, rats were administered YQHXD or celecoxib by oral gavage for 8 weeks, whereas the control and sham-operated groups received normal saline. Histopathological evaluation showed that YQHXD treatment was associated with reduced intervertebral disc degeneration in this model. Enzyme-linked immunosorbent assay, polymerase chain reaction, and western blot analyses showed changes in the mRNA and protein expression levels of selected targets, including AKT1, BCL2, and STAT3. These findings suggest that YQHXD may exert preclinical protective effects in LDD through multi-component and multi-target regulation involving inflammation- and apoptosis-related mechanisms. This study provides preliminary preclinical evidence supporting further investigation of YQHXD for LDD.

Introduction

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Lumbar disc degeneration (LDD) is a common age-related orthopedic condition characterized by late onset, difficulty of treatment, high recurrence, and disability. LDD involves degenerative pathological changes associated with an imbalance between catabolic and anabolic metabolism of the extracellular matrix (ECM) in the intervertebral disc (IVD) and is closely associated with low back pain (LBP)1. Epidemiological studies show that LBP is one of the leading causes of disability in clinical practice2.

From 1990 to 2017, the number of global cases increased from 42.5 million to 64.9 million

Access restricted. Please log in or start a trial to view this content.

Protocol

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

All experiments were approved by the Institutional Review Board of Nanjing University of Chinese Medicine (Protocol Code: 202501A018) and were conducted in accordance with the National Institutes of Health (NIH) Guide for the Care and Use of Laboratory Animals. All experimental procedures adhered to the ARRIVE guidelines.

Experimental drugs
The YQHXD sample solution contained 20 g of Astragalus membranaceus root, 20 g of Angelica sinensis root, 15 g of Ligusticum chuanxiong rhizome, 6 g of Stephania tetrandra root, 15 g of Chaenomeles speciosa fruit, and 10 g of Sinapis....

Access restricted. Please log in or start a trial to view this content.

Results

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Conclusions derived from the study
This study integrated network pharmacology, molecular docking, molecular dynamics simulations, and in vivo experiments to investigate the potential protective effects of YQHXD against LDD. The results suggest that YQHXD may act, at least in part, through regulation of the AKT1/STAT3/BCL-2 signaling axis, characterized by reduced STAT3 expression and increased AKT1 and Bcl-2 expression. Histological and molecular analyses showed that YQHXD treatment was asso.......

Access restricted. Please log in or start a trial to view this content.

Discussion

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Traditional Chinese herbal medicines have been reported to exert pharmacological effects including anti-inflammatory, analgesic, and blood circulation–promoting activities19. Previous studies have suggested that Xiaosui Huahe Decoction, the precursor formula of YQHXD, may promote resorption of massive IVD herniation by affecting nucleus pulposus (NP) resorption and IVD absorption20; however, the underlying molecular mechanisms remain unclear. In the present study, net.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The authors have no conflicts of interest to declare.

Acknowledgements

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

We are grateful to Dr. Jintao Liu from the Affiliated Hospital of Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine Suzhou for their help in all stages of this study. This work was supported by a grant from National Natural Science Foundation of China Project (82474529); Liu 2024, National Natural Science Foundation of China Project (82374220); Jiang 2023, the Natural Science Foundation of Jiangsu Province (NO.BK20250396); the Jiangsu province Traditional Chinese Medicine Science and Technology Development Plan Project (NO. QN202419); the Suzhou Applied Basic Research (medical and health) science and Technology Innovation Project (NO.SYWD2024154....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
0.5% sodium carboxymethylcellulose (CMC-Na)Not specifiedVehicle used to prepare the celecoxib suspension for gavage.
21 G needleNot specifiedUsed for caudal intervertebral disc puncture.
2× Universal Blue SYBR Green qPCR Master MixServicebio Technology Co., Ltd., WuhanG3326qPCR amplification reagent.
30% acrylamide/bis-acrylamide gel solution (29:1)Solarbio Co., Ltd.Gel preparation solution for SDS-PAGE; listed in original materials table as 30%/29:1 gel solution.
3D frozen grinding machineServicebio Technology Co., Ltd., WuhanUsed for tissue homogenization/grinding.
4× SDS-PAGE concentrating gel buffer (pH 6.8)Solarbio Co., Ltd.Western blot gel preparation reagent.
Acidic ethanolNot specifiedUsed for histological staining differentiation.
ACPYPEACPYPE projectUsed to convert ligand topology files into a GROMACS-compatible format.
AKT1 ELISA kitHangzhou UpingBio Technology Co., Ltd.SYP-R1928Used to measure serum AKT1 levels; detection range 0.625–40 ng/mL.
AM1-BCC charge methodAntechamber/AMBER ToolsUsed for ligand atomic charge calculation.
Amber14SB force fieldAMBER force fieldProtein force field used in molecular dynamics simulation.
Angelica sinensis rootJianshou Pharmacy, Nanning, Guangxi, ChinaBatch No. 20250503YQHXD botanical component; 20 g per prescription.
Anhydrous ethanolTianjin Aopusheng Chemical Co., Ltd.Used in tissue processing/dehydration.
AntechamberAMBER ToolsUsed for ligand charge calculation and atom typing.
Anti-AKT1 antibodyWuhan Sanying Co., Ltd.Primary antibody for Western blotting; dilution 1:5,000.
Anti-Bcl-2 antibodyWuhan Sanying Co., Ltd.Primary antibody for Western blotting; dilution 1:1,500.
Anti-STAT3 antibodyWuhan Sanying Co., Ltd.10253-2-APPrimary antibody for Western blotting; dilution 1:6,000.
APS reagentBeyotime/Biyuntian Co.Western blot gel polymerization reagent.
Astragalus membranaceus rootJianshou Pharmacy, Nanning, Guangxi, ChinaBatch No. 20250405YQHXD botanical component; 20 g per prescription.
AutoclaveSANYO, JapanSterilization equipment.
AutoDock Vina engineAutoDock/Vina projectDocking engine used within CB-Dock2.
BCA protein assay kitSolarbio Co., Ltd.Used to determine protein concentration before Western blotting.
Bcl-2 ELISA kitWuhan Fine Biotech Co., Ltd.PMK1545Used to measure serum Bcl-2 levels; detection range 0.16–10 ng/mL.
BupivacaineNot specifiedLocal infiltration anesthetic used preoperatively.
CB-Dock2CB-Dock2 web serverAutomated blind molecular docking platform.
CelecoxibSichuan New Ston Pharmaceutical Co., Ltd.H20233911Positive-control drug; 20 mg/kg/day by gavage.
Chaenomeles speciosa fruitJianshou Pharmacy, Nanning, Guangxi, ChinaBatch No. 231001YQHXD botanical component; 15 g per prescription.
CytoscapeCytoscape ConsortiumVersion 3.9.0Used to construct and analyze network diagrams.
DAB chromogenic reagent kit (20×)Beijing Zhongshan Golden Bridge Biotechnology Co., Ltd.Listed in existing materials table.
DAVIDNational Cancer InstituteVersion 6.8Database for Annotation, Visualization and Integrated Discovery; used for GO and KEGG enrichment analysis.
Decalcification solutionBeijing Zhongshan Golden Bridge Biotechnology Co., Ltd.Used for decalcification of caudal vertebral IVD tissue.
Decolorization shakerLiu Yi Biotechnology Co., Ltd., BeijingLaboratory shaker.
DEPC waterWuhan Sanying Co., Ltd.RNA work/reagent preparation.
Digital radiography imaging systemNot specifiedUsed for postoperative radiographic model validation.
Distilled waterNot specifiedVehicle/control gavage and YQHXD decoction preparation.
ECL chemiluminescent substrateBiosharp Co.Western blot signal detection reagent.
EDTA antigen retrieval solution (pH 8.0)Beijing Zhongshan Golden Bridge Biotechnology Co., Ltd.Listed in existing materials table.
Electrophoresis apparatusNot specifiedUsed for SDS-PAGE electrophoresis.
Electrophoresis bufferServicebio Co.Western blot electrophoresis solution.
FM40 ice makerChangliu Scientific Instruments Co., Ltd., BeijingIce maker.
FormaldehydeNot specifiedFixative used for caudal vertebral IVD tissue.
GAFF2 atom typesAMBER ToolsLigand atom types used for molecular dynamics simulations.
Gel imaging systemTianen Scientific, ShanghaiUsed to capture Western blot images.
GeneCardsWeizmann Institute of ScienceVersion 5.26Human gene database used to retrieve disease-associated targets.
gmx_MMPBSAgmx_MMPBSA projectUsed for MM-PBSA binding free-energy estimation where applicable.
GraphPad PrismGraphPad SoftwareVersion 8.0Statistical/graphing software listed in the authors' earlier manuscript version.
Grinding beadsServicebio Technology Co., Ltd., WuhanUsed for tissue grinding/homogenization.
GROMACSGROMACS development teamVersion 2022.2Used for molecular dynamics simulations.
Hematoxylin and eosin staining reagentsNot specifiedUsed for HE staining of caudal IVD sections.
High-speed centrifugeEppendorf, GermanyLaboratory centrifuge.
High-speed low-temperature tissue grinderServicebio, ChinaUsed for low-temperature tissue grinding.
Horizontal shakerChirinbell CompanyLaboratory shaker.
HRP-labeled goat anti-rabbit antibodyServicebio Co.Secondary antibody for Western blotting; dilution 1:5,000.
HyperScript III RT SuperMix for qPCR with gDNA RemoverServicebio Technology Co., Ltd., WuhanReverse transcription reagent listed in existing materials table.
Ice makerSIMAG, ChinaIce maker.
ImageJNational Institutes of HealthUsed for Western blot band-intensity quantification.
Inverted biological microscopeOlympus, JapanUsed for microscopy of stained sections.
IsofluraneNot specifiedInhalation anesthetic/euthanasia agent.
Isopropanol reagentChina National Pharmaceutical Group Chemical Reagent Co., Ltd.RNA extraction reagent.
Joung-Cheatham ion parametersNot applicableIon parameter set used for molecular dynamics simulations.
Ligusticum chuanxiong rhizomeJianshou Pharmacy, Nanning, Guangxi, ChinaBatch No. 20250301YQHXD botanical component; 15 g per prescription.
Liquid nitrogenNot specifiedUsed for tissue grinding before RNA extraction.
Low-speed centrifugeEppendorf, GermanyUsed for serum separation and other low-speed centrifugation steps.
Masson's trichrome staining solutionNot specifiedUsed for Masson staining of caudal IVD sections.
Microplate reader (TECAN)TECAN, SwitzerlandUsed for absorbance measurement at 450 nm; listed in existing materials table.
Microplate reader (Thermo Fisher Scientific)Thermo Fisher Scientific, USAMultifunctional microplate reader listed in existing materials table.
Microsoft Excel/spreadsheet softwareMicrosoftUsed to remove duplicate target entries and manage tabular data.
NanoDrop 2000 spectrophotometerThermo Fisher Scientific, USAUsed to measure RNA concentration and purity.
Non-enzymatic lysis bufferNot specifiedUsed for tissue lysis before RNA extraction.
OMIMJohns Hopkins University School of MedicineOnline Mendelian Inheritance in Man; used to retrieve disease-associated targets.
Online bioinformatics plotting platformNot specifiedUsed to generate GO and KEGG bar plots.
PAGE gel polymerization agentSolarbio Co., Ltd.Western blot gel preparation reagent.
ParaffinNot specifiedEmbedding medium for histological sections.
PCR primers for Akt1, Bcl-2, Stat3, and GapdhWuhan Servicebio Technology Co., Ltd.Primer sequences are listed in Table 1.
PDBRCSB PDBProtein Data Bank; used to obtain 3D structures of target proteins.
Phosphorylated/protease inhibitorsServicebio Co.Added to RIPA lysis buffer for protein extraction.
Phosphotungstic acidNot specifiedUsed in Masson staining.
Picrosirius RedNot specifiedUsed in Masson staining.
Polyvinylidene difluoride membrane (0.45 μm)Servicebio Co.PVDF membrane used for Western blot transfer.
Positive-control drug vehicleNot specified0.5% CMC-Na suspension vehicle for celecoxib.
Povidone-iodineNot specifiedUsed for surgical site disinfection.
Protein markerThermo Fisher Scientific, USAMolecular weight marker for Western blotting.
Protein transfer apparatusBio-Rad, USAWet transfer equipment for Western blotting.
Protein transfer module (wet transfer)Bio-Rad, USAWestern blot wet transfer module.
PubChemNational Center for Biotechnology Information (NCBI)Used to obtain SMILES/SDF files of compound structures.
Pure water preparation systemLe Feng Biotechnology Co., Ltd., ShanghaiUsed for pure water preparation.
PyMOLSchrödinger, LLCUsed for visualization and analysis of molecular dynamics/docking outputs.
qPCR real-time PCR systemApplied Biosystems QuantStudio, USAUsed for quantitative PCR amplification.
RIPA tissue/cell lysis bufferSolarbio Co., Ltd.Used for total protein extraction.
RNA dissolution solutionServicebio Technology Co., Ltd., WuhanRNA handling reagent.
Rotary evaporatorNot specifiedUsed to concentrate the combined YQHXD filtrates under reduced pressure.
Sinapis alba mature seedsJianshou Pharmacy, Nanning, Guangxi, ChinaBatch No. 20240801YQHXD botanical component; 10 g per prescription.
Sprague-Dawley ratsShanghai Slack Experimental Animal Co., Ltd.SCXK (Shanghai) 2022-0004Seventy male rats, aged 3–8 weeks, used for the caudal-disc puncture model.
SPSSIBM, USAVersion 21.0Statistical software listed in the authors' earlier manuscript version.
STAT3 ELISA kitHangzhou UpingBio Technology Co., Ltd.SYP-R1555Used to measure serum STAT3 levels; detection range 31.25–1000 pg/mL.
Stephania tetrandra rootJianshou Pharmacy, Nanning, Guangxi, ChinaBatch No. 230301YQHXD botanical component; 6 g per prescription.
Sterile gauzeNot specifiedUsed to protect the puncture site after modeling.
STRINGSTRING ConsortiumVersion 12.0Protein-protein interaction network platform.
SweScript All-in-One RT SuperMix for qPCRServicebio Technology Co., Ltd., WuhanG3337Reverse transcription reagent listed in existing materials table.
SwissTargetPredictionSIB Swiss Institute of BioinformaticsUsed to predict potential targets of compounds.
TBST bufferNot specifiedUsed for membrane washing during Western blotting.
TCMSPCenter for Bioinformatics, College of Life Science, Northwest A&F UniversityVersion 2.3Traditional Chinese Medicine Systems Pharmacology Database; used to obtain active ingredients of Chinese herbal compounds.
TIP3P water modelNot applicableWater model used in molecular dynamics simulations.
Toluidine blueNot specifiedUsed in Masson staining.
Transfer bufferServicebio Co.Western blot transfer buffer.
TriQuick reagentServicebio Technology Co., Ltd., WuhanRNA extraction reagent.
TRIzol reagentNot specifiedTotal RNA extraction reagent mentioned in the manuscript.
TTDThe Chinese University of Hong Kong (IDRBLab)Therapeutic Target Database; used to retrieve disease-associated targets.
VennyBioinfoGP, CNB-CSICVersion 2.1.0Used to identify overlapping targets between YQHXD and LDD.
Verlet cutoff schemeGROMACSNon-bonded interaction scheme used in molecular dynamics simulations.
Vertical electrophoresis apparatusBio-Rad, USAUsed for SDS-PAGE.
VMDUniversity of Illinois at Urbana-ChampaignUsed for visualization and analysis of molecular dynamics outputs.
Wet transfer systemBio-Rad, USAUsed for protein transfer in Western blotting.
X-ray fluoroscopy systemNot specifiedUsed to identify caudal IVD levels during puncture modeling.
XyleneNot specifiedUsed for deparaffinization/clearing during histology.
β-actin primary antibodyWuhan Sanying Co., Ltd.Loading-control primary antibody for Western blotting; dilution 1:4,000.

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Tags

Network PharmacologyLumbar Disc DegenerationYi Qi Huo Xue DecoctionMolecular DockingMolecular DynamicsProtein Interaction NetworkPI3K AKT SignalingHistopathological EvaluationEnzyme Linked ImmunosorbentWestern Blot

Related Articles